Quick Answer
Probiotic Depression Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Anxiety is a prevalent non-motor symptom of Parkinson's disease (PD), yet treatment options remain limited.
Key Takeaways
- 01Anxiety is a prevalent non-motor symptom of Parkinson's disease (PD), yet treatment options remain limited. [Lam JST (2026)]
- 02Both the probiotic (n = 30) and placebo (n = 31) groups showed significant within-group improvements on the Parkinson Anxiety Scale, with no significant between-group differences. [Lam JST (2026)]
- 0315 16 17 19 20 21 22 23 24 The emerging evidence supports that there is a bidirectional relationship between gut microbiota and depression, representing a paradigm shift in psychiatric research [,]. [Mosavat Seyed Hamdollah (2026)]
- 04Animal studies have presented some compelling evidence to suggest a causal role of dysbiosis in depression-like behaviours []. [Mosavat Seyed Hamdollah (2026)]
The current Migaku evidence database contains 2 reusable source documents for Probiotic Depression Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Anxiety is a prevalent non-motor symptom of Parkinson's disease (PD), yet treatment options remain limited. [Lam JST (2026); evidence level 2]
- Both the probiotic (n = 30) and placebo (n = 31) groups showed significant within-group improvements on the Parkinson Anxiety Scale, with no significant between-group differences. [Lam JST (2026); evidence level 2]
- 15 16 17 19 20 21 22 23 24 The emerging evidence supports that there is a bidirectional relationship between gut microbiota and depression, representing a paradigm shift in psychiatric research [,]. [Mosavat Seyed Hamdollah (2026); evidence level 2]
- Animal studies have presented some compelling evidence to suggest a causal role of dysbiosis in depression-like behaviours []. [Mosavat Seyed Hamdollah (2026); evidence level 2]
- MDD and SUD often co-occur, with each disorder increasing the risk of developing the other []. [Mosavat Seyed Hamdollah (2026); evidence level 2]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Probiotic supplementation for anxiety symptoms in people with Parkinson's disease: a randomized, double-blind, placebo-controlled trial.
- Effect of probiotic supplement on improvement of depressive symptoms in patients with substance-induced depressive disorder: a randomized, double-blind, placebo-controlled clinical trial